EU Pharma Wants Staggered Approach For Direct Data Capture In Clinical Trials

25 Mar 2019
News

Vibha Sharma @ScripRegVibha vibha.sharma@informa.com

Executive Summary

The European pharmaceutical industry feels the European Medicines Agency's recent opinion on the regulatory acceptability of using eSource Direct Data Capture in clinical trials is promising, but that not all EU countries would be ready for its uptake in the near future.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Regions
Europe
Subjects
Clinical Trials
Regulation
Industries
BioPharmaceutical

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Europe Clinical Trials Regulation

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS124984

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS124984

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

EU Pharma Wants Staggered Approach For Direct Data Capture In Clinical Trials

News

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert